Expression and function of organic cation and anion transporters (SLC22 family) in the CNS

Current Pharmaceutical Design

Volumn 20, Issue 10, 2014, Pages 1472-1486

  Farthing, Christine A ^a   Sweet, Douglas H ^a  

^a VIRGINIA COMMONWEALTH UNIVERSITY   (United States)

Author keywords

Blood brain barrier; Blood cerebrospinal fluid barrier; Brain capillaries; Choroid plexus; Monoamine neurotransmitters; Solute carriers

Indexed keywords

ANTIDEPRESSANT AGENT; CARNITINE TRANSPORTER 1; CARNITINE TRANSPORTER 2; MEMBRANE PROTEIN; ORGANIC ANION TRANSPORTER; ORGANIC ANION TRANSPORTER 1; ORGANIC ANION TRANSPORTER 2; ORGANIC ANION TRANSPORTER 3; ORGANIC CATION TRANSPORTER; ORGANIC CATION TRANSPORTER 1; ORGANIC CATION TRANSPORTER 2; ORGANIC CATION TRANSPORTER 3; PROTEIN SLC22A21; UNCLASSIFIED DRUG;

ANXIETY DISORDER; BEHAVIOR CHANGE; BRAIN; BRAIN CAPILLARY; BRAIN REGION; CENTRAL NERVOUS SYSTEM; CHOROID PLEXUS; DRUG ABUSE; ENDOTHELIUM; EPITHELIUM; HUMAN; IN VITRO STUDY; IN VIVO STUDY; KIDNEY; MONOAMINERGIC SYSTEM; MOOD DISORDER; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; REVIEW; SIGNAL TRANSDUCTION;

ANIMALS; BLOOD-BRAIN BARRIER; CENTRAL NERVOUS SYSTEM; HUMANS; ION TRANSPORT; ORGANIC ANION TRANSPORTERS; ORGANIC CATION TRANSPORT PROTEINS;

EID: 84890464178     PISSN: 13816128     EISSN: 18734286     Source Type: Journal    
DOI: 10.2174/13816128113199990456     Document Type: Review

References (167)

1. Pritchard JB, Miller DS. Mechanisms mediating renal secretion of organic anions and cations. Physiol Rev 1993; 73: 765-96.
2. Wright SH, Dantzler WH. Molecular and cellular physiology of renal organic cation and anion transport. Physiol Rev 2004; 84: 987-1049.
3. Koepsell H, Lips K, Volk C. Polyspecific organic cation transporters: structure, function, physiological roles, and biopharmaceutical implications. Pharm Res 2007; 24: 1227-51.
4. VanWert AL, Gionfriddo MR, Sweet DH. Organic anion transporters: discovery, pharmacology, regulation and roles in pathophysiology. Biopharm Drug Dispos 2010; 31: 1-71.
5. Pacholczyk T, Blakely RD, Amara SG. Expression cloning of a cocaine-and antidepressant-sensitive human noradrenaline transporter. Nature 1991; 350: 350-4.
6. Giros B, Caron MG. Molecular characterization of the dopamine transporter. Trends Pharmacol Sci 1993; 14: 43-9.
7. Lesch KP, Aulakh CS, Wolozin BL, et al. Regional brain expression of serotonin transporter mRNA and its regulation by reuptake inhibiting antidepressants. Brain Res Mol Brain Res 1993; 17: 31-5.
8. Kristensen AS, Andersen J, Jorgensen TN, et al. SLC6 neurotransmitter transporters: structure, function, and regulation. Pharmacol Rev 2011; 63: 585-640.
9. Friedgen B, Wolfel R, Russ H, et al. The role of extraneuronal amine transport systems for the removal of extracellular catecholamines in the rabbit. Naunyn Schmiedebergs Arch Pharmacol 1996; 354: 275-86.
10. Russ H, Staust K, Martel F, et al. The extraneuronal transporter for monoamine transmitters exists in cells derived from human central nervous system glia. Eur J Neurosci 1996; 8: 1256-64.
11. Streich S, Bruss M, Bonisch H. Expression of the extraneuronal monoamine transporter (uptake2) in human glioma cells. Naunyn Schmiedebergs Arch Pharmacol 1996; 353: 328-33.
12. Yamamura HI, Snyder SH. High affinity transport of choline into synaptosomes of rat brain. J Neurochem 1973; 21: 1355-74.
13. Amphoux A, Vialou V, Drescher E, et al. Differential pharmacological in vitro properties of organic cation transporters and regional distribution in rat brain. Neuropharmacology 2006; 50: 941-52.
14. Breidert T, Spitzenberger F, Grundemann D, et al. Catecholamine transport by the organic cation transporter type 1 (OCT1). Br J Pharmacol 1998; 125: 218-24.
15. Busch AE, Quester S, Ulzheimer JC, et al. Electrogenic properties and substrate specificity of the polyspecific rat cation transporter rOCT1. J Biol Chem 1996; 271: 32599-604.
16. Grundemann D, Schechinger B, Rappold GA, et al. Molecular identification of the corticosterone-sensitive extraneuronal catecholamine transporter. Nat Neurosci 1998; 1: 349-51.
17. Kekuda R, Prasad PD, Wu X, et al. Cloning and functional characterization of a potential-sensitive, polyspecific organic cation transporter (OCT3) most abundantly expressed in placenta. J Biol Chem 1998; 273: 15971-9.
18. Murakami H, Sawada N, Koyabu N, et al. Characteristics of choline transport across the blood-brain barrier in mice: correlation with in vitro data. Pharm Res 2000; 17: 1526-30.
19. Wu X, Kekuda R, Huang W, et al. Identity of the organic cation transporter OCT3 as the extraneuronal monoamine transporter (uptake2) and evidence for the expression of the transporter in the brain. J Biol Chem 1998; 273: 32776-86.
20. Wu X, Prasad PD, Leibach FH, et al. cDNA sequence, transport function, and genomic organization of human OCTN2, a new member of the organic cation transporter family. Biochem Biophys Res Commun 1998; 246: 589-95.
21. Zhu HJ, Appel DI, Grundemann D, et al. Evaluation of organic cation transporter 3 (SLC22A3) inhibition as a potential mechanism of antidepressant action. Pharmacol Res 2012; 65: 491-6.
22. Busch AE, Quester S, Ulzheimer JC, et al. Monoamine neurotransmitter transport mediated by the polyspecific cation transporter rOCT1. FEBS Lett 1996; 395: 153-6.
23. Gorboulev V, Ulzheimer JC, Akhoundova A, et al. Cloning and characterization of two human polyspecific organic cation transporters. DNA Cell Biol 1997; 16: 871-81.
24. Martel F, Vetter T, Russ H, et al. Transport of small organic cations in the rat liver. The role of the organic cation transporter OCT1. Naunyn Schmiedebergs Arch Pharmacol 1996; 354: 320-6.
25. Sweet DH, Miller DS, Pritchard JB. Ventricular choline transport: a role for organic cation transporter 2 expressed in choroid plexus. J Biol Chem 2001; 276: 41611-9.
26. Zhang L, Dresser MJ, Gray AT, et al. Cloning and functional expression of a human liver organic cation transporter. Mol Pharmacol 1997; 51: 913-21.
27. Alebouyeh M, Takeda M, Onozato ML, et al. Expression of human organic anion transporters in the choroid plexus and their interactions with neurotransmitter metabolites. J Pharmacol Sci 2003; 93: 430-6.
28. Kusuhara H, Sekine T, Utsunomiya-Tate N, et al. Molecular cloning and characterization of a new multispecific organic anion transporter from rat brain. J Biol Chem 1999; 274: 13675-80.
29. Mori S, Takanaga H, Ohtsuki S, et al. Rat organic anion transporter 3 (rOAT3) is responsible for brain-to-blood efflux of homovanillic acid at the abluminal membrane of brain capillary endothelial cells. J Cereb Blood Flow Metab 2003; 23: 432-40.
30. Ohtsuki S, Takizawa T, Takanaga H, et al. In vitro study of the functional expression of organic anion transporting polypeptide 3 at rat choroid plexus epithelial cells and its involvement in the cerebrospinal fluid-to-blood transport of estrone-3-sulfate. Mol Pharmacol 2003; 63: 532-7.
31. Sekine T, Cha SH, Endou H. The multispecific organic anion transporter (OAT) family. Pflugers Arch 2000; 440: 337-50.
32. Sweet DH, Miller DS, Pritchard JB, et al. Impaired organic anion transport in kidney and choroid plexus of organic anion transporter 3 (Oat3 (Slc22a8) knockout mice. J Biol Chem 2002; 277: 26934-43.
33. Emanuelsson BM, Paalzow L, Sunzel M. Probenecid-induced accumulation of 5-hydroxyindoleacetic acid and homovanillic acid in rat brain. J Pharm Pharmacol 1987; 39: 705-10.
34. Emanuelsson BM, Widerlov E, Walleus H, et al. Determinations of 5-hydroxyindoleacetic acid and homovanillic acid in human CSF with monitoring of probenecid levels in CSF and plasma. Psychopharmacology (Berl) 1987; 92: 144-9.
35. Roffler-Tarlov S, Sharman DF, Tegerdine P. 3, 4-dihydroxyphenylacetic acid and 4-hydroxy-3-methoxyphenylacetic acid in the mouse striatum: a reflection of intra-and extra-neuronal metabolism of dopamine? Br J Pharmacol 1971; 42: 343-51.
36. Grundemann D, Gorboulev V, Gambaryan S, et al. Drug excretion mediated by a new prototype of polyspecific transporter. Nature 1994; 372: 549-52.
37. Green RM, Lo K, Sterritt C, et al. Cloning and functional expression of a mouse liver organic cation transporter. Hepatology 1999; 29: 1556-62.
38. Schweifer N, Barlow DP. The Lx1 gene maps to mouse chromosome 17 and codes for a protein that is homologous to glucose and polyspecific transmembrane transporters. Mamm Genome 1996; 7: 735-40.
39. Terashita S, Dresser MJ, Zhang L, et al. Molecular cloning and functional expression of a rabbit renal organic cation transporter. Biochim Biophys Acta 1998; 1369: 1-6.
40. Monte JC, Nagle MA, Eraly SA, et al. Identification of a novel murine organic anion transporter family member, OAT6, expressed in olfactory mucosa. Biochem Biophys Res Commun 2004; 323: 429-36.
41. Slitt AL, Cherrington NJ, Hartley DP, et al. Tissue distribution and renal developmental changes in rat organic cation transporter mRNA levels. Drug Metab Dispos 2002; 30: 212-9.
42. Meyer-Wentrup F, Karbach U, Gorboulev V, et al. Membrane localization of the electrogenic cation transporter rOCT1 in rat liver. Biochem Biophys Res Commun 1998; 248: 673-8.
43. Urakami Y, Okuda M, Masuda S, et al. Functional characteristics and membrane localization of rat multispecific organic cation transporters, OCT1 and OCT2, mediating tubular secretion of cationic drugs. J Pharmacol Exp Ther 1998; 287: 800-5.
44. Okuda M, Saito H, Urakami Y, et al. cDNA cloning and functional expression of a novel rat kidney organic cation transporter, OCT2. Biochem Biophys Res Commun 1996; 224: 500-7.
45. Walsh RC, Sweet DH, Hall LA, et al. Expression cloning and characterization of a novel organic cation transporter from rat kidney. FASEB Abstracts 1996; 10: A127.
46. Grundemann D, Babin-Ebell J, Martel F, et al. Primary structure and functional expression of the apical organic cation transporter from kidney epithelial LLC-PK1 cells. J Biol Chem 1997; 272: 10408-13.
47. Mooslehner KA, Allen ND. Cloning of the mouse organic cation transporter 2 gene, Slc22a2, from an enhancer-trap transgene integration locus. Mamm Genome 1999; 10: 218-24.
48. Zhang X, Evans KK, Wright SH. Molecular cloning of rabbit organic cation transporter rbOCT2 and functional comparisons with rbOCT1. Am J Physiol Renal Physiol 2002; 283: F124-33.
49. Alnouti Y, Petrick JS, Klaassen CD. Tissue distribution and ontogeny of organic cation transporters in mice. Drug Metab Dispos 2006; 34: 477-82.
50. Sweet DH, Pritchard JB. rOCT2 is a basolateral potential-driven carrier, not an organic cation/proton exchanger. Am J Physiol 1999; 277: F890-8.
51. Karbach U, Kricke J, Meyer-Wentrup F, et al. Localization of organic cation transporters OCT1 and OCT2 in rat kidney. Am J Physiol Renal Physiol 2000; 279: F679-87.
52. Sugawara-Yokoo M, Urakami Y, Koyama H, et al. Differential localization of organic cation transporters rOCT1 and rOCT2 in the basolateral membrane of rat kidney proximal tubules. Histochem Cell Biol 2000; 114: 175-80.
53. Sweet DH, Miller DS, Pritchard JB. Basolateral localization of organic cation transporter 2 in intact renal proximal tubules. Am J Physiol Renal Physiol 2000; 279: F826-34.
54. Verhaagh S, Schweifer N, Barlow DP, et al. Cloning of the mouse and human solute carrier 22a3 (Slc22a3/SLC22A3) identifies a conserved cluster of three organic cation transporters on mouse chromosome 17 and human 6q26-q27. Genomics 1999; 55: 209-18.
55. Tamai I, Yabuuchi H, Nezu J, et al. Cloning and characterization of a novel human pH-dependent organic cation transporter, OCTN1. FEBS Lett 1997; 419: 107-11.
56. Tamai I, Ohashi R, Nezu JI, et al. Molecular and functional characterization of organic cation/carnitine transporter family in mice. J Biol Chem 2000; 275: 40064-72.
57. Wu X, George RL, Huang W, et al. Structural and functional characteristics and tissue distribution pattern of rat OCTN1, an organic cation transporter, cloned from placenta. Biochim Biophys Acta 2000; 1466: 315-27.
58. Tamai I, Nakanishi T, Kobayashi D, et al. Involvement of OCTN1 (SLC22A4) in pH-dependent transport of organic cations. Mol Pharm 2004; 1: 57-66.
59. Yabuuchi H, Tamai I, Nezu J, et al. Novel membrane transporter OCTN1 mediates multispecific, bidirectional, and pH-dependent transport of organic cations. J Pharmacol Exp Ther 1999; 289: 768-73.
60. Nezu J, Tamai I, Oku A, et al. Primary systemic carnitine deficiency is caused by mutations in a gene encoding sodium iondependent carnitine transporter. Nat Genet 1999; 21: 91-4.
61. Tamai I, Ohashi R, Nezu J, et al. Molecular and functional identification of sodium ion-dependent, high affinity human carnitine transporter OCTN2. J Biol Chem 1998; 273: 20378-82.
62. Wu X, Huang W, Prasad PD, et al. Functional characteristics and tissue distribution pattern of organic cation transporter 2 (OCTN2), an organic cation/carnitine transporter. J Pharmacol Exp Ther 1999; 290: 1482-92.
63. Cano MM, Calonge ML, Ilundain AA. Expression of OCTN2 and OCTN3 in the apical membrane of rat renal cortex and medulla. J Cell Physiol 2010; 223: 451-9.
64. Januszewicz E, Bekisz M, Mozrzymas JW, et al. High affinity carnitine transporters from OCTN family in neural cells. Neurochem Res 2010; 35: 743-8.
65. Januszewicz E, Pajak B, Gajkowska B, et al. Organic cation/carnitine transporter OCTN3 is present in astrocytes and is up-regulated by peroxisome proliferators-activator receptor agonist. Int J Biochem Cell Biol 2009; 41: 2599-609.
66. Duran JM, Peral MJ, Calonge ML, et al. OCTN3: A Na+-independent L-carnitine transporter in enterocytes basolateral membrane. J Cell Physiol 2005; 202: 929-35.
67. Lamhonwah AM, Ackerley CA, Tilups A, et al. OCTN3 is a mammalian peroxisomal membrane carnitine transporter. Biochem Biophys Res Commun 2005; 338: 1966-72.
68. Lamhonwah AM, Skaug J, Scherer SW, et al. A third human carnitine/organic cation transporter (OCTN3) as a candidate for the 5q31 Crohn's disease locus (IBD5). Biochem Biophys Res Commun 2003; 301: 98-101.
69. Sekine T, Watanabe N, Hosoyamada M, et al. Expression cloning and characterization of a novel multispecific organic anion transporter. J Biol Chem 1997; 272: 18526-9.
70. Sweet DH, Wolff NA, Pritchard JB. Expression cloning and characterization of ROAT1. The basolateral organic anion transporter in rat kidney. J Biol Chem 1997; 272: 30088-95.
71. Bahn A, Knabe M, Hagos Y, et al. Interaction of the metal chelator 2, 3-dimercapto-1-propanesulfonate with the rabbit multispecific organic anion transporter 1 (rbOAT1). Mol Pharmacol 2002; 62: 1128-36.
72. Cihlar T, Lin DC, Pritchard JB, et al. The antiviral nucleotide analogs cidofovir and adefovir are novel substrates for human and rat renal organic anion transporter 1. Mol Pharmacol 1999; 56: 570-80.
73. George RL, Wu X, Huang W, et al. Molecular cloning and functional characterization of a polyspecific organic anion transporter from Caenorhabditis elegans. J Pharmacol Exp Ther 1999; 291: 596-603.
74. Hagos Y, Bahn A, Asif AR, et al. Cloning of the pig renal organic anion transporter 1 (pOAT1). Biochimie 2002; 84: 1221-4.
75. Hosoyamada M, Sekine T, Kanai Y, et al. Molecular cloning and functional expression of a multispecific organic anion transporter from human kidney. Am J Physiol 1999; 276: F122-8.
76. Lopez-Nieto CE, You G, Bush KT, et al. Molecular cloning and characterization of NKT, a gene product related to the organic cation transporter family that is almost exclusively expressed in the kidney. J Biol Chem 1997; 272: 6471-8.
77. Race JE, Grassl SM, Williams WJ, et al. Molecular cloning and characterization of two novel human renal organic anion transporters (hOAT1 and hOAT3). Biochem Biophys Res Commun 1999; 255: 508-14.
78. Wolff NA, Werner A, Burkhardt S, et al. Expression cloning and characterization of a renal organic anion transporter from winter flounder. FEBS Lett 1997; 417: 287-91.
79. Pritchard JB, Sweet DH, Miller DS, et al. Mechanism of organic anion transport across the apical membrane of choroid plexus. J Biol Chem 1999; 274: 33382-7.
80. Pritchard JB. Coupled transport of p-aminohippurate by rat basolateral membrane vesicles. Am J Physiol 1988; 255: F597-F604.
81. Shimada H, Moewes B, Buckhardt G. Indirect coupling to Na of paminohippuric acid uptake into rat renal basolateral membrane vesicles. Am J Physiol 1987; 253: F795-F801.
82. Sweet DH, Miller DS, Pritchard JB. Localization of an organic anion transporter-GFP fusion construct (rROAT1-GFP) in intact proximal tubules. Am J Physiol 1999; 276: F864-73.
83. Cheng Y, Vapurcuyan A, Shahidullah M, et al. Expression of organic anion transporter 2 in the human kidney and its potential role in the tubular secretion of guanine-containing antiviral drugs. Drug Metab Dispos 2012; 40: 617-24.
84. Kojima R, Sekine T, Kawachi M, et al. Immunolocalization of multispecific organic anion transporters, OAT1, OAT2, and OAT3, in rat kidney. J Am Soc Nephrol 2002; 13: 848-57.
85. Motohashi H, Sakurai Y, Saito H, et al. Gene expression levels and immunolocalization of organic ion transporters in the human kidney. J Am Soc Nephrol 2002; 13: 866-74.
86. Simonson GD, Vincent AC, Roberg KJ, et al. Molecular cloning and characterization of a novel liver-specific transport protein. J Cell Sci 1994; 107 (Pt 4): 1065-72.
87. Sekine T, Cha SH, Tsuda M, et al. Identification of multispecific organic anion transporter 2 expressed predominantly in the liver. FEBS Lett 1998; 429: 179-82.
88. Enomoto A, Takeda M, Shimoda M, et al. Interaction of human organic anion transporters 2 and 4 with organic anion transport inhibitors. J Pharmacol Exp Ther 2002; 301: 797-802.
89. Kobayashi Y, Ohshiro N, Shibusawa A, et al. Isolation, characterization and differential gene expression of multispecific organic anion transporter 2 in mice. Mol Pharmacol 2002; 62: 7-14.
90. Buist SC, Cherrington NJ, Choudhuri S, et al. Gender-specific and developmental influences on the expression of rat organic anion transporters. J Pharmacol Exp Ther 2002; 301: 145-51.
91. Kobayashi Y, Hirokawa N, Ohshiro N, et al. Differential gene expression of organic anion transporters in male and female rats. Biochem Biophys Res Commun 2002; 290: 482-7.
92. Sun W, Wu RR, van Poelje PD, et al. Isolation of a family of organic anion transporters from human liver and kidney. Biochem Biophys Res Commun 2001; 283: 417-22.
93. Cha SH, Sekine T, Fukushima JI, et al. Identification and characterization of human organic anion transporter 3 expressing predominantly in the kidney. Mol Pharmacol 2001; 59: 1277-86.
94. Zhang X, Groves CE, Bahn A, et al. Relative contribution of OAT and OCT transporters to organic electrolyte transport in rabbit proximal tubule. Am J Physiol Renal Physiol 2004; 287: F999-1010.
95. Buist SC, Klaassen CD. Rat and mouse differences in genderpredominant expression of organic anion transporter (Oat1-3; Slc22a6-8) mRNA levels. Drug Metab Dispos 2004; 32: 620-5.
96. Sweet DH, Chan LM, Walden R, et al. Organic anion transporter 3 (Slc22a8) is a dicarboxylate exchanger indirectly coupled to the Na+ gradient. Am J Physiol Renal Physiol 2003; 284: F763-9.
97. Pritchard JB. Rat renal cortical slices demonstrate p-aminohippurate/glutarate exchange and sodium/glutarate coupled paminohippurate transport. J Pharmacol Exp Ther 1990; 255: 969-75.
98. Davson H, Pollay M. Influence of various drugs on the transport of 131-I and PAH across the cerebrospinal-fluid-blood barrier. J Physiol 1963; 167: 239-46.
99. Hug CC, Jr. Transport of narcotic analgesics by choroid plexus and kidney tissue in vitro. Biochem Pharmacol 1967; 16: 345-59.
100. Neff NH, Tozer TN, Brodie BB. Application of steady-state kinetics to studies of the transfer of 5-hydroxyindoleacetic acid from brain to plasma. J Pharmacol Exp Ther 1967; 158: 214-218.
101. Pappenheimer JR, Heisey SR, Jordan EF. Active transport of Diodrast and phenolsulfonphthalein from cerebrospinal fluid to blood. Am J Physiol 1961; 200: 1-10.
102. Tochino Y, Schanker LS. Transport of serotonin and norepinephrine by the rabbit choroid plexus in vitro. Biochem Pharmacol 1965; 14: 1557-1566.
103. Tochino Y, Schanker LS. Active transport of quaternary ammonium compounds by the choroid plexus in vitro. Am J Physiol 1965; 208: 666-73.
104. Cserr HF, VanDyke DH. 5-hydroxyindoleacetic acid accumulation by isolated choroid plexus. Am J Physiol 1971; 220: 718-23.
105. Forn J. Active Transport of 5-Hydroxyindoleacetic Acid by the Rabbit Choroid Plexus In vitro. Biochem Pharmacol 1972; 21: 619-624.
106. Lorenzo AV, Spector R. Transport of salicylic acid by the choroid plexus in vitro. J Pharmacol Exp Ther 1973; 184: 465-71.
107. Pritchard JB. Accumulation of anionic pesticides by rabbit choroid plexus in vitro. J Pharmacol Exp Ther 1980; 212: 354-9.
108. Rubin R, Owens E, Rall D. Transport of methotrexate by the choroid plexus. Cancer Res 1968; 28: 689-94.
109. Suzuki H, Sawada Y, Sugiyama Y, et al. Transport of benzylpenicillin by the rat choroid plexus in vitro. J Pharmacol Exp Ther 1987; 242: 660-5.
110. Villalobos AR, Parmelee JT, Pritchard JB. Functional characterization of choroid plexus epithelial cells in primary culture. J Pharmacol Exp Ther 1997; 282: 1109-16.
111. Villalobos AR, Parmelee JT, Renfro JL. Choline uptake across the ventricular membrane of neonate rat choroid plexus. Am J Physiol 1999; 276: C1288-96.
112. Braandle E, Fritzsch G, Greven J. Affinity of different local anesthetic drugs and catecholamines for the contraluminal transport system for organic cations in proximal tubules of rat kidneys. J Pharmacol Exp Ther 1992; 260: 734-741.
113. Ullrich KJ, Rumrich G, Papavassiliou F, et al. Contraluminal paminohippurate transport in the proximal tubule of the rat kidney. VIII. Transport of corticosteroids. Pflugers Arch 1991; 418: 371-82.
114. Sykes D, Sweet DH, Lowes S, et al. Organic anion transport in choroid plexus from wild-type and organic anion transporter 3 (Slc22a8)-null mice. Am J Physiol Renal Physiol 2004; 286: F972-8.
115. Lowes S, Sykes D, Breen CM, et al. Multiple components of 2, 4-dichlorophenoxyacetic acid uptake by rat choroid plexus. J Pharmacol Exp Ther 2005; 315: 136-43.
116. Nagata Y, Kusuhara H, Endou H, et al. Expression and functional characterization of rat organic anion transporter 3 (rOat3) in the choroid plexus. Mol Pharmacol 2002; 61: 982-8.
117. Nagle MA, Wu W, Eraly SA, et al. Organic anion transport pathways in antiviral handling in choroid plexus in Oat1 (Slc22a6) and Oat3 (Slc22a8) deficient tissue. Neurosci Lett 2013; 534: 133-8.
118. Allen DD, Smith QR. Characterization of the blood-brain barrier choline transporter using the in situ rat brain perfusion technique. J Neurochem 2001; 76: 1032-41.
119. Galea E, Estrada C. Ouabain-sensitive choline transport system in capillaries isolated from bovine brain. J Neurochem 1992; 59: 936-41.
120. Kikuchi R, Kusuhara H, Sugiyama D, et al. Contribution of organic anion transporter 3 (Slc22a8) to the elimination of p-aminohippuric acid and benzylpenicillin across the blood-brain barrier. J Pharmacol Exp Ther 2003; 306: 51-8.
121. Sawada N, Takanaga H, Matsuo H, et al. Choline uptake by mouse brain capillary endothelial cells in culture. J Pharm Pharmacol 1999; 51: 847-52.
122. Lin CJ, Tai Y, Huang MT, et al. Cellular localization of the organic cation transporters, OCT1 and OCT2, in brain microvessel endothelial cells and its implication for MPTP transport across the blood-brain barrier and MPTP-induced dopaminergic toxicity in rodents. J Neurochem 2010; 114: 717-27.
123. Andre P, Saubamea B, Cochois-Guegan V, et al. Transport of biogenic amine neurotransmitters at the mouse blood-retina and blood-brain barriers by uptake1 and uptake2. J Cereb Blood Flow Metab 2012; 32: 1989-2001.
124. Berezowski V, Miecz D, Marszalek M, et al. Involvement of OCTN2 and B0, + in the transport of carnitine through an in vitro model of the blood-brain barrier. J Neurochem 2004; 91: 860-72.
125. Kido Y, Tamai I, Ohnari A, et al. Functional relevance of carnitine transporter OCTN2 to brain distribution of L-carnitine and acetyl-L-carnitine across the blood-brain barrier. J Neurochem 2001; 79: 959-69.
126. Miecz D, Januszewicz E, Czeredys M, et al. Localization of organic cation/carnitine transporter (OCTN2) in cells forming the blood-brain barrier. J Neurochem 2008; 104: 113-23.
127. Lamhonwah AM, Hawkins CE, Tam C, et al. Expression patterns of the organic cation/carnitine transporter family in adult murine brain. Brain Dev 2008; 30: 31-42.
128. Mori S, Ohtsuki S, Takanaga H, et al. Organic anion transporter 3 is involved in the brain-to-blood efflux transport of thiopurine nucleobase analogs. J Neurochem 2004; 90: 931-41.
129. Ohtsuki S, Asaba H, Takanaga H, et al. Role of blood-brain barrier organic anion transporter 3 (OAT3) in the efflux of indoxyl sulfate, a uremic toxin: its involvement in neurotransmitter metabolite clearance from the brain. J Neurochem 2002; 83: 57-66.
130. Ohtsuki S, Kikkawa T, Mori S, et al. Mouse reduced in osteosclerosis transporter functions as an organic anion transporter 3 and is localized at abluminal membrane of blood-brain barrier. J Pharmacol Exp Ther 2004; 309: 1273-81.
131. Gasser PJ, Lowry CA, Orchinik M. Corticosterone-sensitive monoamine transport in the rat dorsomedial hypothalamus: potential role for organic cation transporter 3 in stress-induced modulation of monoaminergic neurotransmission. J Neurosci 2006; 26: 8758-66.
132. Vialou V, Amphoux A, Zwart R, et al. Organic cation transporter 3 (Slc22a3) is implicated in salt-intake regulation. J Neurosci 2004; 24: 2846-51.
133. Vialou V, Balasse L, Callebert J, et al. Altered aminergic neurotransmission in the brain of organic cation transporter 3-deficient mice. J Neurochem 2008; 106: 1471-82.
134. Schmitt A, Mossner R, Gossmann A, et al. Organic cation transporter capable of transporting serotonin is up-regulated in serotonin transporter-deficient mice. J Neurosci Res 2003; 71: 701-9.
135. Inazu M, Takeda H, Matsumiya T. Expression and functional characterization of the extraneuronal monoamine transporter in normal human astrocytes. J Neurochem 2003; 84: 43-52.
136. Cui M, Aras R, Christian WV, et al. The organic cation transporter-3 is a pivotal modulator of neurodegeneration in the nigrostriatal dopaminergic pathway. Proc Natl Acad Sci U S A 2009; 106: 8043-8.
137. Zwart R, Verhaagh S, Buitelaar M, et al. Impaired activity of the extraneuronal monoamine transporter system known as uptake-2 in Orct3/Slc22a3-deficient mice. Mol Cell Biol 2001; 21: 4188-96.
138. Kitaichi K, Fukuda M, Nakayama H, et al. Behavioral changes following antisense oligonucleotide-induced reduction of organic cation transporter-3 in mice. Neurosci Lett 2005; 382: 195-200.
139. Nakayama H, Kitaichi K, Ito Y, et al. The role of organic cation transporter-3 in methamphetamine disposition and its behavioral response in rats. Brain Res 2007; 1184: 260-9.
140. Wultsch T, Grimberg G, Schmitt A, et al. Decreased anxiety in mice lacking the organic cation transporter 3. J Neural Transm 2009; 116: 689-97.
141. Feng N, Mo B, Johnson PL, et al. Local inhibition of organic cation transporters increases extracellular serotonin in the medial hypothalamus. Brain Res 2005; 1063: 69-76.
142. Feng N, Telefont M, Kelly KJ, et al. Local perfusion of corticosterone in the rat medial hypothalamus potentiates D-fenfluramineinduced elevations of extracellular 5-HT concentrations. Horm Behav 2009; 56: 149-57.
143. Rahman S, Bardo MT. Environmental enrichment increases amphetamine-induced glutamate neurotransmission in the nucleus accumbens: a neurochemical study. Brain Res 2008; 1197: 40-6.
144. Schildkraut JJ, Mooney JJ. Toward a rapidly acting antidepressant: the normetanephrine and extraneuronal monoamine transporter (uptake 2) hypothesis. Am J Psychiatry 2004; 161: 909-11.
145. Baganz NL, Horton RE, Calderon AS, et al. Organic cation transporter 3: Keeping the brake on extracellular serotonin in serotonintransporter-deficient mice. Proc Natl Acad Sci U S A 2008; 105: 18976-81.
146. Bacq A, Balasse L, Biala G, et al. Organic cation transporter 2 controls brain norepinephrine and serotonin clearance and antidepressant response. Mol Psychiatry 2012; 17: 926-39.
147. Busch AE, Karbach U, Miska D, et al. Human neurons express the polyspecific cation transporter hOCT2, which translocates monoamine neurotransmitters, amantadine, and memantine. Mol Pharmacol 1998; 54: 342-52.
148. Rytting E, Audus KL. Novel organic cation transporter 2-mediated carnitine uptake in placental choriocarcinoma (BeWo) cells. J Pharmacol Exp Ther 2005; 312: 192-8.
149. Aoyama N, Takahashi N, Kitaichi K, et al. Association between gene polymorphisms of SLC22A3 and methamphetamine use disorder. Alcohol Clin Exp Res 2006; 30: 1644-9.
150. Lazar A, Walitza S, Jetter A, et al. Novel mutations of the extraneuronal monoamine transporter gene in children and adolescents with obsessive-compulsive disorder. Int J Neuropsychopharmacol 2008; 11: 35-48.
151. Taubert D, Grimberg G, Stenzel W, et al. Identification of the endogenous key substrates of the human organic cation transporter OCT2 and their implication in function of dopaminergic neurons. PLoS One 2007; 2: e385.
152. Antkiewicz-Michaluk L, Krygowska-Wajs A, Szczudlik A, et al. Increase in salsolinol level in the cerebrospinal fluid of parkinsonian patients is related to dementia: advantage of a new highperformance liquid chromatography methodology. Biol Psychiatry 1997; 42: 514-8.
153. Naoi M, Maruyama W, Akao Y, et al. Dopamine-derived endogenous N-methyl-(R)-salsolinol: its role in Parkinson's disease. Neurotoxicol Teratol 2002; 24: 579-91.
154. Langston JW, Ballard P. Parkinsonism induced by 1-methyl-4-phenyl-1, 2, 3, 6-tetrahydropyridine (MPTP): implications for treatment and the pathogenesis of Parkinson's disease. Can J Neurol Sci 1984; 11: 160-5.
155. Langston JW, Ballard P, Tetrud JW, et al. Chronic Parkinsonism in humans due to a product of meperidine-analog synthesis. Science 1983; 219: 979-80.
156. Langston JW, Langston EB, Irwin I. MPTP-induced parkinsonism in human and non-human primates--clinical and experimental aspects. Acta Neurol Scand Suppl 1984; 100: 49-54.
157. Hayer-Zillgen M, Bruss M, Bonisch H. Expression and pharmacological profile of the human organic cation transporters hOCT1, hOCT2 and hOCT3. Br J Pharmacol 2002; 136: 829-36.
158. Liou HH, Hsu HJ, Tsai YF, et al. Interaction between nicotine and MPTP/MPP+ in rat brain endothelial cells. Life Sci 2007; 81: 664-72.
159. Shang T, Uihlein AV, Van Asten J, et al. 1-Methyl-4-phenylpyridinium accumulates in cerebellar granule neurons via organic cation transporter 3. J Neurochem 2003; 85: 358-67.
160. Bahn A, Ljubojevic M, Lorenz H, et al. Murine renal organic anion transporters mOAT1 and mOAT3 facilitate the transport of neuroactive tryptophan metabolites. Am J Physiol Cell Physiol 2005; 289: C1075-84.
161. Koepsell H. Organic cation transporters in intestine, kidney, liver, and brain. Annu Rev Physiol 1998; 60: 243-66.
162. Duan H, Wang J. Selective transport of monoamine neurotransmitters by human plasma membrane monoamine transporter and organic cation transporter 3. J Pharmacol Exp Ther 2010; 335: 743-53.
163. Grundemann D, Liebich G, Kiefer N, et al. Selective substrates for non-neuronal monoamine transporters. Mol Pharmacol 1999; 56: 1-10.
164. Suhre WM, Ekins S, Chang C, et al. Molecular determinants of substrate/inhibitor binding to the human and rabbit renal organic cation transporters hOCT2 and rbOCT2. Mol Pharmacol 2005; 67: 1067-77.
165. Haenisch B, Drescher E, Thiemer L, et al. Interaction of antidepressant and antipsychotic drugs with the human organic cation transporters hOCT1, hOCT2 and hOCT3. Naunyn Schmiedebergs Arch Pharmacol; 385: 1017-23.
166. Zhang L, Schaner ME, Giacomini KM. Functional characterization of an organic cation transporter (hOCT1) in a transiently transfected human cell line (HeLa). J Pharmacol Exp Ther 1998; 286: 354-61.
167. Uwai Y, Honjo H, Iwamoto K. Interaction and transport of kynurenic acid via human organic anion transporters hOAT1 and hOAT3. Pharmacol Res 2012; 65: 254-60.